Supply Chain | August 31, 2024
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
MoCRA mandates that all facilities involved in the manufacturing and processing of cosmetic products for sale in the United States
Subscribe To Our Newsletter & Stay Updated
